IL10 and hepatocellular carcinoma: The median level of IL-10 was the highest in the HCC patients, followed by the non-cirrhotic SVRs, with ranges of 2.06–3.78- and 1.45–2-fold higher than those in the control and other groups (P < 0.0001/all), respectively, and none of these values were significantly different from those of the control or each other.